Cargando…
MicroRNA‐338‐3p as a therapeutic target in cardiac fibrosis through FGFR2 suppression
BACKGROUND: The development of cardiac fibrosis involves the activation of cardiac fibroblasts (CFs) and their differentiation into myofibroblasts, which leads to the disruption of the extracellular matrix network. In the past few years, microRNAs (miRNA) have been described as potential targets for...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396162/ https://www.ncbi.nlm.nih.gov/pubmed/35792028 http://dx.doi.org/10.1002/jcla.24584 |